Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease - Keshav, S; Ungashe, S; Zheng, W; Belker, P; Wright, K; Schall, T (2007)